What it is
Treatments that use stem cells, often from your own body, to support tissue repair.
Harnessing the body's own regenerative potential.

At a glance
What it is
Treatments that use stem cells, often from your own body, to support tissue repair.
Why explore it
People explore it for joint, tissue, and recovery goals. Only some uses are established.
How it’s experienced
A clinic visit that may include collecting cells, then an injection or infusion.
Evidence context
Well established for some blood disorders. Most wellness clinic uses are still emerging.
See the evidence snapshotSafety
Higher risk. Use a licensed clinic with approved treatments and question unproven claims.
See staying safeHistory & Origin
Stem cell therapy is a category of regenerative medicine that involves the use of stem cells, the body's foundational, undifferentiated cells, with the goal of supporting tissue repair, reducing inflammation, or potentially restoring cellular function in damaged or degenerating tissues. Stem cells are unique in their ability to self-renew and differentiate into more specialized cell types, which has made them a focal point of both mainstream medical research and emerging wellness applications. Depending on the type and source, stem cells may be derived from a patient's own bone marrow or adipose tissue (autologous), from donated umbilical cord blood or placental tissue (allogeneic), or from other biological sources.
Within conventional medicine, certain stem cell therapies, most notably hematopoietic stem cell transplants for blood-related conditions, are well-established and FDA-approved. However, the broader landscape of stem cell treatments marketed for conditions such as joint degeneration, neurological disorders, or anti-aging purposes occupies a more complex and contested space. Many such offerings exist outside of formal clinical trials and may not yet have sufficient evidence to support their widespread use.
As a category on Gyfts, stem cell therapy sits within the Alternative modality classification, reflecting that while the underlying science is grounded in legitimate biological research, many clinical applications currently being offered, particularly those in direct-to-consumer wellness settings, are considered emerging. Individuals exploring this space are encouraged to approach it with curiosity and careful discernment, consulting qualified medical professionals before pursuing any treatment.
The scientific foundations of stem cell therapy trace back to the mid-twentieth century, when researchers first began investigating the regenerative properties of bone marrow. In the 1950s and 1960s, pioneering work by scientists including E. Donnall Thomas, who later received a Nobel Prize, demonstrated that bone marrow transplantation could reconstitute the blood and immune system in patients who had undergone radiation treatment, laying the groundwork for modern hematological stem cell medicine.
The discovery of human embryonic stem cells in 1998 by James Thomson at the University of Wisconsin opened new chapters of possibility and controversy, triggering intense scientific, ethical, and policy debates that shaped how stem cell research has been funded and regulated ever since. The subsequent development of induced pluripotent stem cells (iPSCs) by Shinya Yamanaka in 2006, which earned a Nobel Prize in 2012, offered a way to create pluripotent stem cells from adult tissue, bypassing many of the ethical concerns associated with embryonic sources.
In parallel with this academic progress, a direct-to-consumer stem cell clinic industry has grown substantially since the 2000s, operating across many countries and offering a wide range of treatments with varying degrees of scientific support. This commercial expansion has prompted ongoing dialogue among scientists, ethicists, and regulators.
Mechanism
Stem cells can renew themselves and develop into specialized cells. Some uses are well established, while many marketed uses are still being studied.
Your first visit
A typical session outline to help you feel prepared
Clinics differ, but a first stem cell consultation often follows the shape below. You can ask about any step, and you do not need to decide at the first visit.
A licensed clinician reviews your health history, current conditions, medications, and past procedures.
You may be asked for imaging and lab results, and screening can include infection, bleeding risk, and pregnancy.
The clinician explains the type of cells, their source, and what research supports for your situation, including where evidence is limited.
You hear about possible risks such as infection, pain, and unwanted immune reactions, and whether the product has regulatory approval or is part of a trial.
You receive written consent forms, a full cost, and time to think or get a second opinion before agreeing to anything.
If you go ahead, cells may be collected and delivered by injection, followed by rest instructions and scheduled check-ins with your own doctor informed.
The evidence
An honest read on how Stem Cell Therapy has been studied — an evidence tier and the research behind it, not a guarantee and not a ranking of “better.”
An emerging area of research
It is important to disclose that the evidence base for most stem cell therapies currently offered in wellness and direct-to-consumer clinical settings is considered emerging.
Early small trials in knee osteoarthritis are encouraging, so results remain uncertain.
Research on these uses is early and unapproved products carry risk, so check with a clinician first and keep it alongside medical care.
Safety first
General guidance to help you decide whether this approach is appropriate for you. This is informational only and not a substitute for medical, psychological, or professional advice.
Some situations call for extra care or a different approach. Share any conditions, injuries, or sensitivities with your practitioner before your first session.
If you are pregnant, managing a health condition, recovering from injury or surgery, or taking medication, consult a qualified healthcare professional first.
Look for clear boundaries, transparent pricing, and practitioners who avoid fear-based claims or pressure to book frequent sessions.
Mild, short-lived effects such as tenderness, tiredness, or temporary soreness can occur. Rest, hydrate, and tell your practitioner how you respond.
For you?
A simple, human way to weigh it up. This is general guidance, not personal medical advice — a qualified practitioner can advise on your situation.
Gyfts is a discovery platform, not a medical provider. Nothing here diagnoses, treats or replaces professional care. In an emergency, contact your local emergency number.
Explore approaches
Other practices people often explore alongside stem cell therapy.
In their words
Before you book
FAQ
Certain stem cell therapies, particularly bone marrow transplants for blood-related conditions, are FDA-approved and well-established. However, many stem cell treatments offered in wellness and direct-to-consumer clinic settings have not received FDA approval and exist outside of formal regulatory frameworks. The FDA has issued warnings about unapproved stem cell products, and individuals are encouraged to verify the regulatory status of any treatment they are considering.
Response timelines vary considerably depending on the condition being addressed, the type of cells used, and individual biology. Some individuals report noticing changes within weeks, while others describe gradual shifts over several months. Because the evidence base is still emerging, there is no reliable universal timeline, and outcomes can differ significantly from person to person.
Autologous stem cell therapy uses cells harvested from the patient's own body, typically from bone marrow or fat tissue, which may reduce the risk of immune rejection. Allogeneic therapy uses cells donated from another individual, often from umbilical cord or placental tissue, and may carry different immune considerations. Both approaches are being studied across a range of applications, though neither is broadly approved for most wellness-focused indications.
It depends on the clinic, the type of cells, and the condition being addressed. In many autologous procedures, cells are first collected, either by bone marrow aspiration from the hip area or by a minimally invasive removal of fat tissue. The collected material is then processed before use. Ask your doctor to explain each step and its risks, since procedures vary considerably.
Risks depend on the type of therapy, the source of the cells, and the clinic. Some procedures may involve infection at the harvest or injection site, immune reactions with donated cells, and in rare reported cases, tumor formation or unintended tissue growth. The FDA has warned about clinics offering unapproved products. Talk with your doctor before pursuing it, and verify the regulatory status of any procedure you consider.
References
Educational sources that inform this overview. Inclusion is for context and does not imply endorsement.
Full citations are maintained by the Gyfts editorial team and reviewed periodically.
Keep exploring
Browse practitioners, explore honest overviews, and take what you learn to a conversation — at your own pace.